Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Squamous Cell

Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.

1,631 public trials 442 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Squamous Cell trial results

Completed

Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer

NCT03521570

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Cleveland Clinic Foundation Cleveland, Ohio, United States
  • Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

NCT03693612

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +33 more
Locations
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site New York, United States
  • GSK Investigational Site Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy

NCT06063941

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations
  • Ankang Central Hospital Ankang, Shaanxi, China
  • Xijing Hospital of Digestive Diseases Xi'an, Shaanxi, China
  • Air Force 986 Hospital Xi'an, Shaanxi, China
  • Xi'an International Medical Center Hospital Xi'an, Shaanxi, China
View Trial Details
Completed

Combination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck

NCT01064479

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +29 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson Regional Care Center-Katy Houston, Texas, United States
  • MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
  • MD Anderson Regional Care Center-Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

NCT02383927

Conditions
Carcinoma, Carcinoma, Squamous Cell, Endocrine Gland Neoplasms, +13 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • Wihship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
View all 35 locations
View Trial Details
Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details

Related conditions